SCHEMBL17909479

SCHEMBL17909479

CCOC(=O)CCCOCCOCCOCC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.47
▸ MAPT P10636 1/20 0.41
▸ NR1I2 O75469 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ DGKA P23743 1/20 0.39
▸ MGAM O43451 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ SI P14410 1/20 0.38
▸ MGAM2 Q2M2H8 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ TDP1 Q9NUW8 3/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17909300 1.00 CYP1A2 (0.47) CYP1A2MAPTNR1I2PGRADORA3
SCHEMBL17909164 1.00 CYP1A2 (0.47) CYP1A2MAPTNR1I2PGRADORA3
SCHEMBL10596343 0.90 MAPT (0.49) CYP1A2MAPTDGKAGAAALDH1A1
SCHEMBL17909674 0.89 MAPT (0.43) MAPTDGKAGAAALDH1A1TDP1
SCHEMBL17909047 0.89 MAPT (0.43) MAPTDGKAGAAALDH1A1TDP1
SCHEMBL17909245 0.89 MAPT (0.43) MAPTDGKAGAAALDH1A1TDP1
SCHEMBL17908994 0.88 DGKA (0.46) CYP1A2MAPTDGKAALDH1A1TDP1
SCHEMBL17909645 0.88 DGKA (0.46) CYP1A2MAPTDGKAALDH1A1TDP1
SCHEMBL17909641 0.88 DGKA (0.46) CYP1A2MAPTDGKAALDH1A1TDP1
SCHEMBL17908808 0.87 DGKA (0.49) MAPTDGKAALDH1A1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048093-B1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORP (JP) 2019-02-20 — — EP disclosed
US-10077229-B2 Ether-containing monoester compound and use thereof MORESCO CORPORATION (JP) 2018-09-18 — — US disclosed
EP-3048093-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF Moresco Corporation (JP) 2016-07-27 — — EP disclosed
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORPORATION (JP) 2016-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077229-B2 Ether-containing monoester compound and use thereof SFN, CCNE2, HSD3B2 CYP1A2 382/4885MAPT 3437/4885NR1I2 840/4885
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF SFN, CCNE2, MSMO1 CYP1A2 403/4885MAPT 3717/4885NR1I2 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback